These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Conant K; Garzino-Demo A; Nath A; McArthur JC; Halliday W; Power C; Gallo RC; Major EO Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3117-21. PubMed ID: 9501225 [TBL] [Abstract][Full Text] [Related]
6. The human immunodeficiency virus type-1 transcription factor Tat produces elevations in intracellular Ca2+ that require function of an N-methyl-D-aspartate receptor polyamine-sensitive site. Self RL; Mulholland PJ; Nath A; Harris BR; Prendergast MA Brain Res; 2004 Jan; 995(1):39-45. PubMed ID: 14644469 [TBL] [Abstract][Full Text] [Related]
7. Synergistic increases in intracellular Ca2+, and the release of MCP-1, RANTES, and IL-6 by astrocytes treated with opiates and HIV-1 Tat. El-Hage N; Gurwell JA; Singh IN; Knapp PE; Nath A; Hauser KF Glia; 2005 Apr; 50(2):91-106. PubMed ID: 15630704 [TBL] [Abstract][Full Text] [Related]
8. PDGF-mediated protection of SH-SY5Y cells against Tat toxin involves regulation of extracellular glutamate and intracellular calcium. Zhu X; Yao H; Peng F; Callen S; Buch S Toxicol Appl Pharmacol; 2009 Oct; 240(2):286-91. PubMed ID: 19576918 [TBL] [Abstract][Full Text] [Related]
9. Neuroprotective activity of chemokines against N-methyl-D-aspartate or beta-amyloid-induced toxicity in culture. Bruno V; Copani A; Besong G; Scoto G; Nicoletti F Eur J Pharmacol; 2000 Jul; 399(2-3):117-21. PubMed ID: 10884510 [TBL] [Abstract][Full Text] [Related]
10. HIV-1 Tat induces monocyte chemoattractant protein-1-mediated monocyte transmigration across a model of the human blood-brain barrier and up-regulates CCR5 expression on human monocytes. Weiss JM; Nath A; Major EO; Berman JW J Immunol; 1999 Sep; 163(5):2953-9. PubMed ID: 10453044 [TBL] [Abstract][Full Text] [Related]
11. Induction of monocyte chemoattractant protein-1 (MCP-1/CCL2) gene expression by human immunodeficiency virus-1 Tat in human astrocytes is CDK9 dependent. Khiati A; Chaloin O; Muller S; Tardieu M; Horellou P J Neurovirol; 2010 Mar; 16(2):150-67. PubMed ID: 20370601 [TBL] [Abstract][Full Text] [Related]
12. HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines. El-Hage N; Wu G; Wang J; Ambati J; Knapp PE; Reed JL; Bruce-Keller AJ; Hauser KF Glia; 2006 Jan; 53(2):132-46. PubMed ID: 16206161 [TBL] [Abstract][Full Text] [Related]
13. Sustained activation of ERK signaling in astrocytes is critical for neuronal injury-induced monocyte chemoattractant protein-1 production in rat corticostriatal slice cultures. Katayama T; Sakaguchi E; Komatsu Y; Oguma T; Uehara T; Minami M Eur J Neurosci; 2010 Apr; 31(8):1359-67. PubMed ID: 20384770 [TBL] [Abstract][Full Text] [Related]
14. Tat, a human immunodeficiency virus-1-derived protein, augments excitotoxic hippocampal injury in neonatal rats. Wang P; Barks JD; Silverstein FS Neuroscience; 1999 Jan; 88(2):585-97. PubMed ID: 10197777 [TBL] [Abstract][Full Text] [Related]
19. U50,488 inhibits HIV-1 Tat-induced monocyte chemoattractant protein-1 (CCL2) production by human astrocytes. Sheng WS; Hu S; Lokensgard JR; Peterson PK Biochem Pharmacol; 2003 Jan; 65(1):9-14. PubMed ID: 12473373 [TBL] [Abstract][Full Text] [Related]
20. HIV-1 tat protein induces a migratory phenotype in human fetal microglia by a CCL2 (MCP-1)-dependent mechanism: possible role in NeuroAIDS. Eugenin EA; Dyer G; Calderon TM; Berman JW Glia; 2005 Mar; 49(4):501-10. PubMed ID: 15578658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]